Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Fruzaqla (fruquintinib) / Takeda

NCT06202599: Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance

Completed

N/A

124

RoW

Fruquintinib

Peking University People's Hospital

Bone Sarcoma, Soft Tissue Sarcoma, Refractory Tumor

08/23

11/23

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites